EMpagliflozin to PREvent worSening of Left Ventricular Volumes and Systolic Function After Myocardial Infarction

NCT05020704 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Myocardial Infarction

Interventions

DRUG: Empagliflozin 10 MG
DRUG: Placebo

Sponsor

NHS Greater Glasgow and Clyde

Collaborators

[object Object]